Osteopontin-Targeted and PPARδ-Agonist-Loaded Nanoparticles Efficiently Reduce Atherosclerosis in Apolipoprotein E<sup>–/

Osteopontin-Targeted and PPARδ-Agonist-Loaded Nanoparticles Efficiently Reduce Atherosclerosis in Apolipoprotein E^–/– Mice

Published:2022-08-15 Issue:33 Volume:7 Page:28767-28778
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Huang Xu¹²,Zhang Yang¹,Zhang Weiwei³,Qin Cheng¹,Zhu Yan³,Fang Yan¹,Wang Yabin¹^ORCID,Tang Chengchun²,Cao Feng¹^ORCID

Affiliation:

1. Department of Geriatric Cardiology, National Clinical Research Center for Geriatric Diseases, 2nd Medical Center, Chinese PLA General Hospital, Beijing 100853, China

2. Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China

3. Nankai University School of Medicine, Nankai University, Tianjin 300073, China

Funder

Ministry of Science and Technology of the People's Republic of China

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Capital Clinical Feature Research Project

Beijing Tianjin and Hebei Special Foundation

Chinese PLA General Hospital

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c00575

Reference52 articles.

1. Atherosclerosis

2. Imaging Atherosclerosis

3. Vascular Cell Adhesion Molecule-Targeted MS2 Viral Capsids for the Detection of Early-Stage Atherosclerotic Plaques

4. Lipid-Lowering Drugs: Are Adverse Effects Predictable and Reversible?

5. Osteopontin – A multi-modal marker and mediator in atherosclerotic vascular disease

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers That Seem to Have the Greatest Impact on Promoting the Formation of Atherosclerotic Plaque in Current Scientific Research;Current Issues in Molecular Biology;2024-08-29

2. Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis;Medicine in Drug Discovery;2024-06

3. Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers;Exploration;2023-12-07

4. Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics;Advanced Functional Materials;2023-03-31

5. Osteopontin: A Bone-Derived Protein Involved in Rheumatoid Arthritis and Osteoarthritis Immunopathology;Biomolecules;2023-03-09